This summer, the PD[N]ano Lab hosted two NDnano Undergraduate Research Fellowship (NURF) students, Jack Latilla Campbell and Kolbe Schlosser, both of the University of Notre Dame. Working at the intersection of nanoscience, engineering, and precision medicine, each took on one of oncology’s hardest problems: how to kill a tumor without poisoning the patient. Chemotherapy has …
Category Archive: Label-free
Oct 30
2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting
Great job by the Nallathamby lab (PDNANO) members Conor, Kevin and Carlie at presenting our work on antibacterials, and cancer therapeutics to the @ND_IPH advisory board! Great input from the advisory board members on possible collaborations and translational paths forward. #GoIrish#NDResearch#MDR#curecancer All three presenters have publications with us which formed the basis for these poster …
Jan 09
Nallathamby Lab at the Society for Biomaterials/ Japanese Society for Biomaterials (Jan 8-10, 2022) Hawaii
Virtually presented our lab’s research on tackling two pressing problems in biomedical research at the Society for Biomaterials/ Japanese Society for Biomaterials joint Symposium in Honolulu, Hawaii. (January 8-10, 2022). I am presenting our research on broad-spectrum antibiotic-free antibacterials to combat multi-drug resistant bacterial infections. Oral Presentation Session: Session 1: Bioglasses/Ceramics/Other Hard Materials2:37 – 2:52 …
Jun 20
ACS-Institutional Research Grant -Phase II Grant Funded to Mitigate Cardiotoxicity of Chemotherapeutics using our Nanocarriers
Excited that our phase-II proposal to the American Cancer Society’s Institutional Research Grant (ACS-IRG) program was funded. This was upon successful phase I completion of our proposal for a novel magnetically driven drug nanocarrier. We propose to use these drug nanocarriers to mitigate cardiotoxicity in the new study. The data generated by the study funded …





Recent Comments